Legitimate access runs through a licensed telehealth provider, a medical spa or clinic, or a pharmacy dispensing an FDA-approved drug under prescription
Multiple meta-analyses further revealed this complexity: A meta-analysis on the body component modification effect of GLP-1 receptor agonists showed that compared with the control group, GLP-1RA users not only had a significant reduction in fat body mass, but also a more obvious reduction in lean body mass (weighted mean difference was 1.02 kg) [55]
Tesamorelin GHRH analog, FDA-approved (Egrifta) for visceral fat reduction
Brello Health falls into that middle category, but barely
In these select patients, surgical sphincterotomy must be considered carefully
They are supported by clinical trial data on the specific formulation